PHARMACOLOGIC SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) IMAGING OR PHARMACOLOGIC ECHOCARDIOGRAPHY? A META ANALYSIS OF PHARMACOLOGIC TESTING FOR DIAGNOSIS OF HIGH-RISK CORONARY ARTERY DISEASE.
نویسندگان
چکیده
منابع مشابه
Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.
UNLABELLED In July 2009, the Medical Advisory Secretariat (MAS) began work on Non-Invasive Cardiac Imaging Technologies for the Diagnosis of Coronary Artery Disease (CAD), an evidence-based review of the literature surrounding different cardiac imaging modalities to ensure that appropriate technologies are accessed by patients suspected of having CAD. This project came about when the Health Ser...
متن کاملappropriateness of referrals for single-photon emission computed tomography myocardial perfusion imaging (spect-mpi) in iran
abstract is not available
متن کاملNon-Pharmacologic Treatments for Fear of Flying
The purpose of the present survey was to review the important Non-pharmacologic treatments for fear of flying up to the present. This study is in the same way as some studies. Accordingly, some Non-pharmacologic treatments for fear of flying were assessed through this systematic review article. The general conclusion from the information provided by the former studies, shows that a growing num...
متن کاملExercise echocardiography versus 201Tl single-photon emission computed tomography in evaluation of coronary artery disease. Analysis of 292 patients.
BACKGROUND Exercise echocardiography (digital cine-loop technique) and 201Tl single-photon emission computed tomography (SPECT) were performed simultaneously in 292 patients being evaluated for coronary artery disease. METHODS AND RESULTS Pretreadmill and posttreadmill echocardiographic images of diagnostic quality were obtained in 289 patients, and the left ventricle was divided into anterio...
متن کاملTargeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease
INTRODUCTION Diagnosis of Alzheimer's disease (AD) in vivo, by molecular imaging of amyloid or tau, is constrained because similar changes can be found in brains of cognitively normal individuals. Butyrylcholinesterase (BChE), which becomes associated with these structures in AD, could elevate the accuracy of AD diagnosis by focusing on BChE pathology in the cerebral cortex, a region of scant B...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2010
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(10)60900-x